DE69738600D1 - Neuroaktive peptide - Google Patents

Neuroaktive peptide

Info

Publication number: DE69738600D1
Authority: DE; Germany
Prior art keywords: neuroactive peptides; val; neuroactive; peptides; angiotensin
Prior art date: 1996-07-09
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE69738600T

Other languages

English (en)

Other versions

DE69738600T2 (de

Inventor

Frederick A Mendelsohn

Siew Yeen Chai

Ingrid Moeller

Peter G Aldred

Ian A Smith

Rebecca A Lew

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Florey Institute of Neuroscience and Mental Health

Original Assignee

Howard Florey Institute of Experimental Physiology and Medicine

Florey Institute of Neuroscience and Mental Health

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-07-09

Filing date

1997-07-09

Publication date

2008-05-08

1997-07-09 Application filed by Howard Florey Institute of Experimental Physiology and Medicine, Florey Institute of Neuroscience and Mental Health filed Critical Howard Florey Institute of Experimental Physiology and Medicine

2008-05-08 Publication of DE69738600D1 publication Critical patent/DE69738600D1/de

2009-07-23 Application granted granted Critical

2009-07-23 Publication of DE69738600T2 publication Critical patent/DE69738600T2/de

2017-07-10 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
NBQSSMDPPLHNDC-GSOGOTFGSA-N (2s)-2-[[(2s)-2-[[(2s)-5-amino-2-[[(2s,3r)-2-[[(2s)-2-[[(2s)-1-[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-4-methylpentanoyl]amino]-3-methylbutanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-(1h-indol-3-yl)pr Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=C(O)C=C1 NBQSSMDPPLHNDC-GSOGOTFGSA-N 0.000 abstract 1
QSBGWDDCOJYQGY-KOQODJNWSA-N Angiotensin IV Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)C(C)C)C1=CC=C(O)C=C1 QSBGWDDCOJYQGY-KOQODJNWSA-N 0.000 abstract 1
102400000349 Angiotensin-4 Human genes 0.000 abstract 1
101800000737 Angiotensin-4 Proteins 0.000 abstract 1
101800005093 LVV-hemorphin-7 Proteins 0.000 abstract 1
230000004071 biological effect Effects 0.000 abstract 1
230000001537 neural effect Effects 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/14—Angiotensins: Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/795—Porphyrin- or corrin-ring-containing peptides
- C07K14/805—Haemoglobins; Myoglobins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Biomedical Technology (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Neurosurgery (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Vascular Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

DE69738600T 1996-07-09 1997-07-09 Neuroaktive peptide Expired - Lifetime DE69738600T2 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
AUPO089396		1996-07-09
AUPO0893A AUPO089396A0 (en)	1996-07-09	1996-07-09	Neuroactive peptide
PCT/AU1997/000436 WO1998001465A1 (en)	1996-07-09	1997-07-09	Neuroactive peptide

Publications (2)

Publication Number	Publication Date
DE69738600D1 true DE69738600D1 (de)	2008-05-08
DE69738600T2 DE69738600T2 (de)	2009-07-23

Family

ID=3795208

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE69738600T Expired - Lifetime DE69738600T2 (de)	1996-07-09	1997-07-09	Neuroaktive peptide

Country Status (9)

Country	Link
US (1)	US7026280B2 (de)
EP (1)	EP0917535B1 (de)
JP (1)	JP4275738B2 (de)
AT (1)	ATE390440T1 (de)
AU (1)	AUPO089396A0 (de)
CA (1)	CA2259137A1 (de)
DE (1)	DE69738600T2 (de)
NZ (1)	NZ333632A (de)
WO (1)	WO1998001465A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20050020519A1 (en) *	2001-08-02	2005-01-27	Albiston Anthony L.	Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at4) receptor activity
EG23584A (en) *	2003-11-11	2006-09-11	Ali Mokhtar Al-Hossary Amr	Elimination of myoglobin from blood using an i v filter
CA2619481A1 (en) *	2005-08-23	2007-03-01	Wyeth	Methods for the treatment of anxiety and for identification of anxiolytic agents
US9066901B2 (en) *	2006-07-07	2015-06-30	Washington State University	C-Met receptor regulation by angiotensin IV (AT4) receptor ligands
US9623084B2 (en)	2013-03-15	2017-04-18	University Of Southern California	Methods for treating multiple sclerosis
US9732074B2 (en)	2013-03-15	2017-08-15	University Of Southern California	Methods, compounds, and compositions for the treatment of angiotensin-related diseases
RU2727162C1 (ru) *	2019-09-17	2020-07-21	Общество С Ограниченной Ответственностью "Герофарм"	Композиция полипептидов, обладающая свойством нормализовать функции головного мозга
RU2727167C1 (ru) *	2019-09-17	2020-07-21	Общество С Ограниченной Ответственностью "Герофарм"	Композиция полипептидов, обладающая свойством нормализовать функции головного мозга

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5063206A (en) *	1988-12-16	1991-11-05	The United States Of Americas As Represented By The Department Of Health And Human Services	Compositions having use as treatment of neuropsychiatric deficits
US5599907A (en) *	1989-05-10	1997-02-04	Somatogen, Inc.	Production and use of multimeric hemoglobins
US5861483A (en) *	1996-04-03	1999-01-19	Pro-Neuron, Inc.	Inhibitor of stem cell proliferation and uses thereof

1996
- 1996-07-09 AU AUPO0893A patent/AUPO089396A0/en not_active Abandoned
1997
- 1997-07-09 WO PCT/AU1997/000436 patent/WO1998001465A1/en not_active Ceased
- 1997-07-09 AT AT97929027T patent/ATE390440T1/de not_active IP Right Cessation
- 1997-07-09 US US09/147,490 patent/US7026280B2/en not_active Expired - Fee Related
- 1997-07-09 NZ NZ333632A patent/NZ333632A/en not_active IP Right Cessation
- 1997-07-09 DE DE69738600T patent/DE69738600T2/de not_active Expired - Lifetime
- 1997-07-09 JP JP50458698A patent/JP4275738B2/ja not_active Expired - Fee Related
- 1997-07-09 EP EP97929027A patent/EP0917535B1/de not_active Expired - Lifetime
- 1997-07-09 CA CA002259137A patent/CA2259137A1/en not_active Abandoned

Also Published As

Publication number	Publication date
AUPO089396A0 (en)	1996-08-01
JP4275738B2 (ja)	2009-06-10
ATE390440T1 (de)	2008-04-15
US20020147129A1 (en)	2002-10-10
EP0917535A4 (de)	2001-11-21
EP0917535A1 (de)	1999-05-26
WO1998001465A1 (en)	1998-01-15
US7026280B2 (en)	2006-04-11
JP2001504803A (ja)	2001-04-10
CA2259137A1 (en)	1998-01-15
DE69738600T2 (de)	2009-07-23
NZ333632A (en)	2000-06-23
EP0917535B1 (de)	2008-03-26

Similar Documents

Publication	Publication Date	Title
NZ263344A (en)	1997-08-22	Human bactericidal/permeability increasing (bpi) protein functional domain peptides and their use
DE69833948D1 (de)	2006-05-11	Aktives system zur frühen zerstörung von schleppwirbeln
CA2181150A1 (en)	1995-07-20	Biologically Active Peptides from Functional Domains of Bactericidal/Permeability-Increasing Protein and Uses Thereof
ATE410441T1 (de)	2008-10-15	Zusammensetzungen und methoden zur behandlung von infektionen unter verwendung von indolicidinanalogen
ATE197307T1 (de)	2000-11-15	Neuroaktive peptide
ATE286740T1 (de)	2005-01-15	Zyklische peptide mit breitspektrum antimikrobieller aktivität
ID24520A (id)	2000-07-20	Analog-analog peptida lh-rh, penggunaannya dan komposisi farmasi yamg mengandungnya
DE69938786D1 (de)	2008-07-03	Die verwendung von peptiden von il-2 und peptid-derivaten als therapeutische wirkstoffe
ATE280777T1 (de)	2004-11-15	Bradykinin-antagonist peptide mit n- substituierten glycinen
PT896615E (pt)	2003-01-31	Peptido proveniente de uma forma soluvel de acetilcolinesterase activo como modulador dos canais de calcio
DE69839566D1 (de)	2008-07-10	Chimäre polypeptide, die das fragment b des shigatoxins sowie peptide von therapeutischem interesse enthalten
BR9813817A (pt)	2000-10-10	Análogos de hemiasterlina
DE69931482D1 (de)	2006-06-29	Isolierte peptide die aminosäuresequenzen von ny-eso-1 entsprechen und an mhc-klasse i und mhc klasse ii moleküle binden, und deren verwendungen
ATE390440T1 (de)	2008-04-15	Neuroaktive peptide
DK0687180T3 (da)	2000-11-27	Fremgangsmåde til påvisning og behandling af individer, som har unormale celler, som udtrykker HLC-A2/tyrosinasepeptid-anti
ATE385805T1 (de)	2008-03-15	Neue peptide
ID23184A (id)	2000-03-23	Garam-garam peptida bpc dengan aktivitas organoprotektif proses pembuatan dan penggunaannya dalam terapi
DE59410423D1 (de)	2006-01-12	Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose
DE69726602D1 (en)	2004-01-15	Hepatitis b inhibitoren
EP0717752A4 (de)	1997-08-20	Therapeitische inhaltsstoffe
NO20023914L (no)	2002-10-11	Preparater for anvendelse for regulering av aktiviteten til parkingenet
ES2122912A1 (es)	1998-12-16	Inhibidores de metalocarboxipeptidasas y moleculas derivadas como agentes antitumorales.
DZ2803A1 (fr)	2003-12-01	Polypeptide de la protéine c humaine.
ATE174927T1 (de)	1999-01-15	Haemoregulatorische penta-oder hexapeptide
DE59609353D1 (de)	2002-07-25	Mittel zur subkutanen Verabreichung von Protein C

Legal Events

Date	Code	Title	Description
2009-04-16	8364	No opposition during term of opposition